Peptide Amphiphile Nanofiber Paste for Bone Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for bone and tissue defects, such as bone resorption and nonunion, lack effective solutions for bone regeneration and growth factor delivery, particularly in accommodating irregular defect shapes and providing sustained release of growth factors.
Innovation Solution
A composite of peptide amphiphiles and biocompatible particles is used to create a slurry paste that gels in the shape of the defect, incorporating growth factors and cells, allowing for osteoconductive and osteoinductive properties and sustained growth factor release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If a slurry paste of peptide amphiphile nanofiber solution mixed with solid biocompatible particles is used, then the material can be adapted into any size bone defect and gels in the shape of the defect, but the complexity of the composition increases
Solution Approach 1:
The patent combines peptide amphiphile nanofibers with solid biocompatible particles (such as collagen, hydroxyapatite, or tricalcium phosphate) to create a composite slurry paste. This composite structure allows the material to maintain flowability for adaptation to various defect shapes while the nanofiber network provides gelation capability. The biocompatible particles contribute to osteoconductivity and structural support, resolving the contradiction between adaptability and composition complexity by integrating multiple functional components into a unified composite system.
Solution Approach 2:
The patent utilizes changes in physical parameters (viscosity, gelation temperature, pH) of the peptide amphiphile nanofiber solution to transform the slurry paste from a flowable state during application to a gel state after implantation. This parameter change allows the material to be easily adapted to defect shapes in its liquid form, then fixed in place as a gel, reducing the operational complexity despite the sophisticated composition.
2Duration of action of moving object
If growth factors are incorporated into the nanofiber gel for sustained release, then bone regeneration is enhanced, but the manufacturing precision and control of release kinetics become more difficult
Solution Approach 1:
The peptide amphiphile nanofibers act as an intermediary carrier for growth factors. The nanofiber network provides a controlled environment that binds and releases growth factors in a sustained manner. The biocompatible particles embedded in the gel serve as additional intermediaries that can adsorb and release growth factors over time. This intermediary system enables sustained release (improving duration of action) while the natural binding and release mechanisms of the nanofibers and particles provide inherent control over release kinetics without requiring complex manufacturing processes.
Solution Approach 2:
The nanofiber gel forms a porous three-dimensional network structure that physically entraps growth factors. This porous architecture allows for controlled diffusion of growth factors from the interior of the gel to the surrounding tissue. The pore size and distribution can be tuned by adjusting the nanofiber concentration and composition, providing a degree of control over release kinetics through physical structure rather than complex chemical modifications, thus balancing sustained release with manufacturing feasibility.
3Stability of the object's composition
If the paste is designed to gel after implantation, then the material maintains its shape in the defect site, but the ease of operation during application is reduced
Solution Approach 1:
The patent designs the slurry paste with dynamic rheological properties that allow it to transition from a flowable state during application to a stable gel state after implantation. The peptide amphiphile nanofibers remain in a sol state at lower concentrations or temperatures, allowing easy injection and adaptation to defect shapes. Upon implantation, changes in temperature, pH, or ionic strength trigger gelation, transforming the material into a stable, shape-retaining gel. This dynamic behavior resolves the contradiction by providing ease of operation during application followed by stable shape maintenance in situ.
Solution Approach 2:
The patent exploits phase transitions of the peptide amphiphile nanofibers to control the state of the slurry paste. The nanofibers can transition between sol (liquid) and gel phases in response to environmental cues such as temperature changes, pH shifts, or ionic strength variations. During application, the paste is maintained in the sol phase for ease of handling and adaptation. After implantation, the phase transition to gel occurs automatically, providing shape stability. This phase transition mechanism enables the material to satisfy both ease of operation and shape stability requirements at different stages of the procedure.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composite effectively promotes bone regeneration and growth factor delivery, achieving high fusion rates in spinal fusion models and addressing the challenges of defect shape accommodation and sustained growth factor release.
Implementation Method 1
compositions comprise a slurry paste of a peptide amphiphile nanofiber solution mixed with solid biocompatible particles
Implementation Method 2
After implantation, the nanofibers cause the paste to gel in the shape of the bone defect
Data Source
AI summary
Provided herein are compositions comprising a composite of peptide amphiphiles and biocompatible particles and methods of use thereof for treatment of bone and/or tissue defects. In particular, compositions comprise a slurry paste of a peptide amphiphile nanofiber solution mixed with solid biocompatible particles, and find use in tissue/bone regeneration, growth factor delivery, and/or cell delivery.